Back

Homeopathic and Low Dose Products for Cancer Prevention and Treatment

principle Investigators: Wayne B. Jonas, MD; Radha K. Maheshwari, PhD

Affiliations: Uniformed Services University of Health Sciences (USUHS); National Institutes of Health; Amala Cancer Research Center, India; Industrial Toxicology Research Center, Lucknow, India

Co-Founders: NCCAM, NCI, NIH

Background: The use of homeopathic remedies and low-dose carcinogens for cancer treatment and prevention has been more prevalent outside of the United States. Reports of successful treatments have been verified by the NIH Best Case Series program. This multi-year project exploits collaboration between USUHS and Indian research laboratories, and the capacity to perform lower cost screening efforts in India. Some homeopathic medicines will be found to have cellular impact on a variety of cancers, including breast, prostate, lung, liver, brain, oral and cervical. Prescreening work in India will allow a cost effective way to determine which remedies have the potential to work against which cancers.

Hypotheses: Low dose carcinogens have anticarcinogenic effects. This project explores the anticarcinogenic effects of low dose cancer agents and homeopathic treatments for their ability to prevent and treat cancer.

Method and Materials: This program is located at the Uniformed Services University of the Health Sciences (USUHS), laboratories at the National Institutes of Health (NIH), and two laboratories in India. In the first year, primary screening for activity of homeopathic medicines and low dose cancer agents against various cancers is being pursued. This screening in animal models is done in India. Positive results from this preliminary work will be confirmed and further studies will be pursued with state of the art molecular biology techniques at USUHS and NIH. Advanced genetic techniques will be performed at the National Institutes of Health, and through contract laboratories.

Anticipated results: The cellular and genetic effects of homeopathic cadmium preparations in normal and prostate cancer cells will be initially examined. This program will document the clinical affects of homeopathic treatment and identify which remedies are most promising for further study. It will also reveal the degree and mechanisms of these effects in animal and cellular models.

Relationship to SIIB mission and healing: The potential of impacting cancer, one of the most feared of chronic diseases, could significantly change the view of conventional practitioners toward complementary and alternative medicine, and provide new non-toxic approaches to this disease.


 





Funded Research